The Sanofi Patient Assistance form is a comprehensive document designed to connect eligible U.S. residents with certain prescription medications and vaccines at no cost through the Sanofi Patient Connection® program. This assistance is aimed at those who meet specific eligibility requirements, including financial criteria. If you think you might qualify and need help accessing your medication, consider filling out the form by clicking the button below.
In today's healthcare landscape, the cost of prescription medications and vaccines can pose a significant barrier, preventing many individuals from accessing the treatments they need to live healthy lives. Recognizing this challenge, Sanofi Patient Connection® offers a lifeline to eligible US residents facing financial barriers that hinder their access to necessary Sanofi prescription medications and vaccines. Through the Patient Assistance Connection segment of this program, participants may receive select Sanofi prescription medications and vaccines at no cost, provided they meet certain eligibility criteria related to residency, healthcare supervision, income, insurance status, and age for vaccines. The application process is designed to be straightforward: complete the application form, secure the necessary signatures, and submit it through specified channels. However, ensuring all information is correct and complete is crucial, as any missing details could delay the application process. Beyond immediate access to medications, the program offers additional support services to address broader needs that could be beneficial for applicants. This comprehensive approach underlines Sanofi Cares North America's commitment to not just alleviating the financial burden of medication costs but also to supporting the overall well-being of its applicants.
APPLICATION
Sanofi Patient Connection® is a program (the “Program”) to help you get access to the medications and resources you need at no cost. Patient Assistance Connection is part of the Program that provides select Sanofi prescription medications and vaccines, at no cost, if you meet certain eligibility requirements. Patient Assistance Connection is made possible through Sanofi Cares North America.
Who may be eligible for Patient Assistance Connection?
In order to be eligible for this portion of the Program, you must meet the following requirements:
•You must be a resident of the U.S. or the U.S. territories and be under the care of a licensed healthcare provider authorized to prescribe, dispense and administer medicine in the U.S.
•You must have an annual household income of [≤400%] of the current Federal Poverty Level. If you may be eligible for Medicaid, you will be required to provide documentation of Medicaid denial before being assessed for patient assistance eligibility.
•If you are enrolled in Medicare Part D, you may also be eligible based on the income criteria noted above.
•You must have no insurance coverage or, for commercially insured patients, have no access to the prescribed product or treatment via your insurance.
•For Vaccines, you must be 19 years of age or older (except for IMOVAX® Rabies and IMOGAM® Rabies-HT).
How do I apply?
Complete page 2, sign page 3, then bring or send the form to your healthcare provider to complete and sign page 4. Missing information may delay processing of your application. Your completed application may be submitted by your healthcare provider as follows:
U.S. Mail
Fax
Secure Provider Portal*
Sanofi Patient Connection
1.888.847.1797
www.visitspconline.com
PO Box 222138
*Excluding Mozobil® and Thymoglobulin®
Charlotte, NC 28222-2138
What happens next?
When we receive your application, we will review it to see if you qualify for Patient Assistance Connection. If you are eligible:
1.You and your healthcare provider will receive a letter notifying you of enrollment. If you are a Medicare Part D patient, your plan sponsor will also receive a letter notifying it of your enrollment.
2.You will be enrolled for 12 months. If you are a Medicare Part D patient, you will be enrolled through the end of the calendar year.
3.Your medication will be sent directly to your healthcare provider’s office in approximately 5-7 business days from when you are approved.
If you do not qualify for Patient Assistance Connection, we will send you and your healthcare provider a letter with the reason for denial.
Do not include Patient Medical Records with this application.
© 2021 Sanofi US Services, Inc.
P: 1.888.847.4877 · F: 1.888.847.1797
1 of 5
P.O. Box 222138 · Charlotte, NC · 28222-2138
MAT-US-2109597-v1.0-11/2021
1. PATIENT INFORMATION
First Name
Gender
M F
Phone
MI
DOB
Email Address
Last Name
SSN
Primary Language
Address
City
State
Zip Code
Household Size
1 2 3 4 5 Other:
Annual Household
Income
I permit Sanofi Patient Connection to speak with the following person and/or organization about the information on this application and the status of my application request.
Patient Representative/Organization Name
Relationship to Patient
2. PATIENT INSURANCE INFORMATION
Insurance?
Yes
No
If yes, is it Medicare Part D?
Primary Insurance
Secondary Insurance
Policy #
Group #
Policyholder Name
Insurance Phone
3. RESOURCE CONNECTION
Do you want the Program to help identify resources provided by other organizations?
Please note: You will receive a separate call from a Program associate with contact information for helpful resources checked on your application.
If yes, please mark which resources you may be interested in if available:
Yes (PATIENT SIGNATURE FOR AUTHORIZATION IN SECTION 4 REQUIRED)
No
Clinical Support Services Transportation Information
Health Supplies
Nutritional Supplements (groceries, food banks, etc.)
Home Care Services (shelter, utilities, etc.)
Other (Please Elaborate):
2 of 5
4. PATIENT AUTHORIZATION (REQUIRED)
Please read the following carefully, then date and sign where indicated below.
Income Verification: Sanofi Patient Connection and its authorized third party agents will use my date of birth or social security number and/or additional demographic information as needed to access my credit information and information derived from public and other sources to estimate my income in conjunction with the eligibility determination process. As a soft credit inquiry, this option will not impact my credit score . Sanofi Patient Connection and its authorized third party agents reserve the right to ask for additional documents and information at any time.
I state that the information and documents provided in connection with this application are complete and accurate. I agree to immediately inform a Program representative and my Doctor/ Healthcare Provider if my income or insurance status changes during the course of my participation in this Program.
HIPAA Consent: I authorize my healthcare providers and staff; my health insurer, health plan or programs that provide me health benefits (together, “Health Insurers”) to disclose to, Sanofi US, its affiliated companies (i.e. Sanofi Pasteur U.S. and Genzyme, a Sanofi Comp any), Sanofi Cares North America, and authorized third party agents involved in administration of this Program, (collectively “Program Sponsor”), health information about me, including information related to my medical condition, treatment, health insurance coverage, claims, prescriptions and referral to and enrollment in this Program for purposes of determining my participation in, and administering, the Program, which may include contacting me as well as my Doctor/Healthcare Provider, office/hospital staff, insurer (public/private) or others. I understand a representative from Sanofi may contact me for follow-up on any adverse event I may report regarding a Sanofi product. I authorize and consent to release of identifiable information about me including medical, financial and insurance records and information as required for participation in the Program. I understand that identifiable information about me will be kept confidential and will not be further used or disclosed except to administer the Program, or as required by law. I understand that information I authorize to be disclosed may be re-disclosed and is no longer protected by Federal privacy regulations. I agree that this authorization is voluntary and that I may refuse to sign this authorization. Refusal to sign will not affect my ability to obtain treatment but I will not be able to participate in this Program. Unless revoked, this authorization shall remain in effect throughout my participation in the Program, including subsequent reapplication as required. I may withdraw this authorization at any time by written notification to my Doctor/Healthcare Provider; however, withdrawal of authorization will terminate my participation in this Program and will not affect information already disclosed under this Authorization.
I understand that it is my responsibility to follow-up with my prescriber or the Program to make sure that my re-orders, as appropriate, are requested in a timely manner by my Provider so I do not run out of medication. I understand that Sanofi US and Sanofi Cares North America reserve the right at any time and without notice to modify or change eligibility criteria or discontinue this Program.
Patient Authorization (REQUIRED)
By signing below, I acknowledge that I have read and agree to the Patient Authorization to
Use and Disclose Health Information above.
Patient/Representative Signature (REQUIRED)
Printed Name
Date
5. PATIENT CONSENT
I authorize the Program to contact me by mail, telephone, or e-mail, with information about the Program, disease state and products, promotions, services, and research studies, and to ask my opinion about such information and topics, including market research and disease-related surveys. I further authorize the Program to de-identify my health information and use it in performing research, including linkage with other de-identified information the Program receives from other sources, education, business analytics, marketing studies, or for other commercial purposes. I understand that entities operating or administering parts of the Program may share identifiable health information with one another in order to de-identify it for these purposes and as needed to perform the Services or to send the communications listed above (the “Communications”). I understand and agree that the Program may use my health information for these purposes and may share my health information with my doctors, specialty pharmacies, and insurers. I understand that I may be contacted by the Program in the event that I report an adverse event associated with a Sanofi product.
I understand that I do not have to opt in to receive the Communications, and that I can still receive patient assistance through the Program, as prescribed by my physician. I may opt out of receiving Communications offered by the Program, at any time by notifying a Program representative by telephone at 1-800- 633-1610 or by mailing a letter to Sanofi US Customer Services, P.O. Box 5925 Mailstop 55A-220A5, Bridgewater, NJ 08807-5925. I also understand that the Services may be revised, changed, or terminated at any time.
Patient Consent
By signing below, I acknowledge that I have read and agree to the Patient Consent above.
Patient/Representative Signature
3 of 5
6. TO BE COMPLETED BY THE HEALTHCARE PROVIDER (HCP)
Please check the appropriate box (prescriber and patient signature required for all applications)
Patient Assistance
Benefits Verification (BV) and Patient
BV only
No cost medication program. Check this
Assistance
Insurance coverage research program.
box if patient does not have health
Insurance coverage research and no cost
Check this box if only insurance coverage
insurance coverage.
medication program. Check this box if the
research is desired.
patient has insurance coverage.
7. TREATMENT AND PRESCRIBING INFORMATION
Patient Name
Medication #1
Medication #2
ICD-10 Code
Vials
Pens
N/A
Dosage (# of units per day)
Qty
8. PRESCRIBER INFORMATION
Prescriber Name
State Where
Licensed
License #
NPI #
Tax ID #
DEA #
Facility Name
Facility Address*
Office Contact Name
Title/Role
Primary Phone
Primary Fax
Primary Email
*Sanofi product must be shipped to the signing prescriber’s office or hospital address authorized by the prescriber and not to a 3rd party.
I certify that the information provided is current, complete, and accurate to the best of my knowledge. I certify that the Sanofi product is medically necessary for this patient and that I am authorized under State law to prescribe and dispense the requested medication. I certify that I have obtained from my patient all required written authorization for the release of my patient’s personal identification, medical and insurance information to Sanofi US and/or Sanofi Cares North America and their agents and representatives. I understand that any information provided is for the sole use of the Program to verify my patient’s insurance coverage, to assess, if applicable, patient’s eligibility for participation in the Patient Assistance Program and to otherwise administer the Sanofi Patient Connection Program and related services. I understand that I am under no obligation to prescribe any Sanofi product and that I have not received, nor will I receive, any benefit from Sanofi or their agents or representatives for prescribing a Sanofi product. The facility address noted above in Section 8 is my office or hospital address. My signature certifies that any prescription products received from this Program will be used for the above-named patient only and will not be resold nor offered for sale, trade or barter and will not be returned for credit, nor will payment be sought from any payer, patient or other source for product received from the Program.
Prescriber Signature (REQUIRED – no stamps)
SIGN
HERE
4 of 5
9. PRODUCT SELECTION
•Adacel® (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed)
•Adlyxin® (lixisenatide) injection
•Admelog® (insulin lispro injection) 100 Units/mL
•Apidra® (insulin glulisine injection) 100 Units/mL
•Imogam® Rabies-HT Immune Globulin, [Human] USP, Heat Treated
•Imovax® Rabies Vaccine [Human Diploid Cell]
•Lantus® (insulin glargine injection) 100 Units/mL
•Lovenox® (enoxaparin sodium injection)*1
•Menactra® Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diptheria Toxoid Conjugate Vaccine
•Mozobil® (plerixafor injection)1
•Multaq® (dronedarone) Tablets*
•Pentacel® Diptheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine
•Priftin® (rifapentine) Tablets
•Soliqua® 100/33 (insulin glargine & lixisenatide) injection 100 Units/mL and 33 mcg/mL
•Tenivac® (tetanus and diphtheria toxoids adsorbed)
•Thymoglobulin® [Anti-Thymocyte Globulin (Rabbit)]*,1
•Toujeo® (insulin glargine injection) 300 Units/mL (1.5 mL or 3.0 mL pens)**
*Please see full U.S. prescribing information, including Black Box warning.
**Regular SoloStar® is packaged as 3 pens per pack 450 units/pen; dials up to 80 units per single injection. Max SoloStar® is packaged as 2 pens per pack 900 units/pen; dials up to 160 units per single injection; Max pen dials in 2-unit increments.
1If applying for Drug Replacement (Lovenox®, Mozobil®, and Thymoglobulin®), a copy of the claim, denial, flow sheet(s) and drug dispensing log (with patient name, date of service, product NDC/Lot #, total dosage) must be submitted.
Full U.S. prescribing information for all Sanofi Patient Connection supported products can be accessed at www.visitspconline.com. Sanofi Patient Connection will provide assistance for any medically appropriate use as described in the prescribing information.
10. WHAT DOES A SUCCESSFUL PATIENT ASSISTANCE CONNECTION APPLICATION LOOK LIKE?
To apply for Patient Assistance Connection all information must be complete and include the following:
Patient Information:
•Complete all relevant information on page 2, and sign and date the Patient Authorization on page 3 (REQUIRED).
Healthcare Provider:
•Ask your Healthcare Provider (HCP) to complete page 4 and sign and date it.
•Ask your HCP to mail, fax, or submit through the Provider Portal your completed application.
Missing information may delay processing of application.
11. ADDITIONAL INFORMATION
•Sanofi Patient Connection ships most medications in a 90-day supply.
•A representative from Sanofi may contact you for follow-up on any adverse event you may report regarding a Sanofi product.
12. FORM SUBMISSION OPTIONS
5 of 5
P:1.888.847.4877 · F: 1.888.847.1797 P.O. Box 222138 · Charlotte, NC · 28222-2138
After you've determined that you are eligible for the Sanofi Patient Assistance Connection, completing the application form is the next vital step towards gaining access to prescribed Sanofi medications and vaccines at no cost. Ensuring that every section of the application is filled out thoroughly and accurately is crucial for a smooth processing experience. Missing or incorrect information can lead to delays, so attentiveness to detail is key. Here are the steps you need to follow to correctly fill out the form.
After completing the form, review it with your healthcare provider to ensure all information is accurate and no sections are missed. Your HCP can then submit the application through mail, fax, or the Secure Provider Portal, except for applications involving Mozobil® and Thymoglobulin®. Keep a copy for your records and await confirmation of your enrollment from Sanofi, after which your medications will be shipped directly to your healthcare provider's office.
What is the Sanofi Patient Connection Program?
The Sanofi Patient Connection Program is a comprehensive support initiative designed to help individuals access Sanofi medications and resources at no cost. This patient assistance component of the Program provides select Sanofi prescription medications and vaccines free of charge, subject to eligibility criteria. The Program operates out of Sanofi Cares North America and aims to assist eligible U.S. residents and those in U.S. territories who are under the care of a licensed healthcare provider.
Who is eligible for the Patient Assistance Connection?
To be eligible for this part of the Program, applicants must be U.S. or U.S. territory residents receiving care from a healthcare provider licensed to prescribe, dispense, and administer medicine in the U.S. Their annual household income must be at or below 400% of the current Federal Poverty Level. Eligibility also depends on the applicant's insurance status—those with no insurance coverage, commercially insured patients without access to the prescribed product or treatment through their insurance, or Medicare Part D enrollees meeting the income criteria may qualify. For vaccine assistance, applicants must be 19 years of age or older, with specific exceptions noted.
How does one apply for assistance through the Program?
Applicants must complete and sign the application form, ensuring all relevant information is accurately provided. The healthcare provider must then complete their portion of the form and also sign it. Completed applications can be submitted by mail, fax, or through the Secure Provider Portal (with certain product exceptions). It is crucial to provide all requested information to avoid delays in the processing of the application.
What occurs after an application is submitted?
Upon receipt of a completed application, it undergoes a review process to determine the applicant's eligibility. Approved applicants and their healthcare providers are informed via a letter about enrollment, which lasts for 12 months—or through the end of the calendar year for Medicare Part D patients. Medications are then shipped directly to the healthcare provider’s office within 5-7 business days. If an application is denied, a letter explaining the reason for the denial will be sent.
Does applying to the Program affect one’s credit score?
No, applying to the Sanofi Patient Connection Program does not affect the applicant’s credit score. The Program may perform a soft credit inquiry as part of income verification during the eligibility determination process, which does not impact credit scoring.
Can changes in financial or insurance status affect Program eligibility?
Yes, participants are responsible for informing the Program representative and their healthcare provider immediately if there are any changes in income or insurance status during their participation. Such changes could potentially affect eligibility for assistance through the Program.
When completing the Sanofi Patient Assistance form, people often make crucial mistakes that can lead to delays or even denial of assistance. One common mistake is incompletely filling out the patient information section. Every piece of requested information, including contact details and household size, is essential for determining eligibility. Overlooking even a single field may result in the application being flagged for additional information, thereby delaying the process.
Another significant error is neglecting to provide complete insurance information. The form requires details of any existing insurance, including Medicare Part D coverage. Failure to accurately disclose insurance status or incorrectly indicating Medicare Part D coverage can mislead the reviewing committee about the applicant's true eligibility, particularly given that specific criteria apply depending on insurance status. This step is crucial, especially for those with limited or no insurance, as it directly impacts eligibility evaluation.
A further mistake involves the documentation of Medicaid denial for those who could potentially qualify for Medicaid. Applicants sometimes forget to attach or fail to obtain this necessary document. Given that eligibility for the Sanofi program requires proof of Medicaid denial for those who might qualify, skipping this step can halt the application process entirely, preventing those in need from accessing vital medication.
Many applicants also overlook the resource connection section, which is designed to identify additional support services that the applicant may benefit from. Failure to indicate interest in these resources means missing out on potentially valuable assistance with transportation, nutritional supplements, and more, beyond the prescription assistance sought.
Lastly, a common oversight is the failure to properly complete the healthcare provider's section and ensuring their signature is on the form. This portion is essential as it contains verification of the medical need for Sanofi products and confirms the healthcare provider’s role in the applicant’s care. An application missing the healthcare provider's detailed information and signature will not be processed, as this is a mandatory step in verifying the necessity and appropriateness of the requested medication for the patient.
When applying for the Sanofi Patient Assistance Connection, a thorough and accurate submission of required forms and supporting documents ensures a swift and favorable review process. It's essential to understand the myriad of documents that often accompany or are requested along with the Sanofi Patient Assistance form to bolster an application. Below is a list of such documents, each serving its unique purpose in the application process:
Adequately preparing and submitting the appropriate documents alongside the Sanofi Patient Assistance form can expedite the processing time and facilitate access to the necessary medications. It's imperative to review each document for accuracy and completeness before submission to avoid delays. More information on the requirements for each of these documents can usually be found within the application instructions or by contacting the program directly.
The Sanofi Patient Assistance form shares similarities with the Pfizer Patient Assistance Program Application form. Both are designed to offer medications at no cost to eligible patients who cannot afford them. These applications require detailed personal, medical, and financial information to determine eligibility, emphasizing their aim to support those in financial need. Each form demands a healthcare provider’s involvement, ensuring the medication requested is medically necessary. This process includes physician certification regarding the patient's health status and the prescribing information, underlining the safeguard mechanisms to ensure appropriate and justified patient assistance.
Comparable to the Merck Patient Assistance Program Enrollment Form, the Sanofi form mandates detailed insurance information and a segment dedicated to verifying patient eligibility for other government or insurance benefits. Both forms scrutinize the patient's insurance status to ensure the program supports those most in need, particularly targeting individuals without insurance coverage or those ineligible to claim their prescribed medication through insurance. Such forms highlight a multi-tiered approach to patient assistance, prioritizing an exhaustive eligibility check to focus aid on underinsured or uninsured individuals.
Similar to the Novartis Patient Assistance Foundation Application, the Sanofi form includes a patient consent section for the use and disclosure of health information. This section is crucial for compliance with privacy laws and guidelines, such as the Health Insurance Portability and Accountability Act (HIPAA). It permits the collection, use, and disclosure of personal and health information for program administration purposes. This parallel shows an industry standard in handling sensitive patient data, ensuring participants understand their privacy rights and the scope of consent.
The Lilly Cares Foundation Patient Assistance Program application is akin to the Sanofi form in its requirement for comprehensive treatment and prescribing information. Both applications necessitate details on the medication prescribed, dosage, and treatment duration, supplied by the healthcare provider. This ensures the assistance provided aligns precisely with the patient’s needs while streamlining the process to prevent any unnecessary delays in receiving aid. This approach underscores the programs’ commitment to delivering targeted support to patients.
Like the Amgen Safety Net Foundation application, the Sanofi form solicits a signed patient authorization, underscoring the importance of informed consent in the patient assistance process. This legally binding section ensures patients are fully aware of the terms, conditions, and the scope of the assistance program, including how their information will be used. This mutual understanding fosters transparency between the patient, healthcare provider, and the pharmaceutical company, establishing a trust foundation vital for such assistance programs.
The HealthWell Foundation’s application for assistance bears resemblance to the Sanofi form in its provisions for emergency shipments or expedited processing for urgent cases. While not explicitly stated in every section of the Sanofi form, the streamlined process for receiving medication—direct shipping to healthcare providers' offices—hints at a structure designed to minimize delays in patient care. This reflects a shared industry focus on ensuring timely access to medications for those in critical need, underscoring the humanitarian goals underpinning these programs.
Lastly, the Assistance Foundation for Accessible Medications application parallels the Sanofi form in its segment offering additional resources beyond the primary assistance scope. Both provide options for patients to indicate interest in supplementary support services, including disease education and support for insurance navigation. This holistic approach to patient aid reflects a broader understanding of the challenges facing individuals with chronic or serious illnesses, acknowledging that medication access is only one aspect of comprehensive care.
Filling out the Sanofi Patient Assistance form accurately and completely is crucial to accessing needed medications and resources at no cost. Here are some key dos and don'ts to help guide you through the process:
Here are four common misconceptions about the Sanofi Patient Assistance form and clarifications for each:
When applying for the Sanofi Patient Assistance Connection, it's crucial to understand the key elements that make the application process smooth and ensure access to necessary medications. Here are pivotal takeaways to guide applicants through this process:
Understanding and adhering to these key points can significantly impact the successful enrollment into the Sanofi Patient Assistance Connection, facilitating access to necessary medications for eligible patients.
How to Change Address With Irs - It is crucial for maintaining up-to-date records with the IRS, ensuring compliance with tax obligations.
Automobile Salesperson - The MVA CS-043 form is a necessary document for individuals seeking a new or transfer vehicle salesman’s license in Maryland.
Genealogy Research Forms - Document aiding in the collection and verification of familial ties to Revolutionary War veterans or supporters.